{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:46:53Z","timestamp":1764402413596},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.11.072","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T15:34:25Z","timestamp":1228923265000},"page":"803-814","source":"Crossref","is-referenced-by-count":41,"title":["International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19\u201320 July 2007"],"prefix":"10.1016","volume":"27","author":[{"given":"M.L.","family":"Tondella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Carlone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Messonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.D.","family":"Meade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Guiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.L.","family":"Hewlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giammanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Wirsing von K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hueston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Mink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.T.","family":"Poolman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.W.","family":"Hildreth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"RR-17","key":"10.1016\/j.vaccine.2008.11.072_bib1","first-page":"1","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR-3","key":"10.1016\/j.vaccine.2008.11.072_bib2","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"33","key":"10.1016\/j.vaccine.2008.11.072_bib3","first-page":"837","article-title":"Outbreaks of respiratory illness mistakenly attributed to pertussis\u2014New Hampshire, Massachusetts, and Tennessee, 2004\u20132006","volume":"56","author":"CDC","year":"2007","journal-title":"MMWR"},{"issue":"June (6 Suppl.)","key":"10.1016\/j.vaccine.2008.11.072_bib4","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/01.inf.0000166154.47013.47","article-title":"Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination","volume":"24","author":"Edwards","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"November (18)","key":"10.1016\/j.vaccine.2008.11.072_bib5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2008.11.072_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1473-3099(02)00452-8","article-title":"Pertussis of adults and infants","volume":"2","author":"Wirsing von Konig","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2008.11.072_bib7","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/01.inf.0000160920.75623.a3","article-title":"Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations","volume":"24","author":"Wirsing von Konig","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2008.11.072_bib8","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1086\/426020","article-title":"New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative","volume":"39","author":"Forsyth","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2008.11.072_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3201\/eid0604.000404","article-title":"Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data","volume":"6","author":"de Melker","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2008.11.072_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJMp068288","article-title":"The control of pertussis\u20142007 and beyond","volume":"356","author":"Halperin","year":"2007","journal-title":"N Engl J Med"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2008.11.072_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.072_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1473-3099(03)00669-8","article-title":"How best to estimate the global burden of pertussis?","volume":"3","author":"Crowcroft","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2008.11.072_bib13","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/01.inf.0000160921.74004.12","article-title":"Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations","volume":"24","author":"Forsyth","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2008.11.072_bib14","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/01.inf.0000160912.58660.87","article-title":"Health burden of pertussis in adolescents and adults","volume":"24","author":"Rothstein","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.072_bib15","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2004-2648","article-title":"The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection","volume":"115","author":"Cherry","year":"2005","journal-title":"Pediatrics"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2008.11.072_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1586\/14737159.6.6.857","article-title":"Diagnosis of pertussis: a historical review and recent developments","volume":"6","author":"Wendelboe","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2008.11.072_bib17","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.inf.0000160926.89577.3b","article-title":"Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives","volume":"24","author":"Cherry","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2008.11.072_bib18","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/JCM.35.10.2435-2443.1997","article-title":"Laboratory diagnosis of pertussis: state of the art in 1997","volume":"35","author":"Muller","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2008.11.072_bib19","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JCM.43.10.4925-4929.2005","article-title":"Nucleic Acid amplification tests for diagnosis of Bordetella infections","volume":"43","author":"Riffelmann","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"June (Pt 6)","key":"10.1016\/j.vaccine.2008.11.072_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1099\/jmm.0.45624-0","article-title":"Laboratory diagnosis of pertussis infections: the role of PCR and serology","volume":"53","author":"Fry","year":"2004","journal-title":"J Med Microbiol"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2008.11.072_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.diagmicrobio.2008.02.017","article-title":"Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp.","volume":"61","author":"Tatti","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2008.11.072_bib22","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1128\/JCM.40.8.2801-2805.2002","article-title":"Issues associated with and recommendations for using PCR to detect outbreaks of pertussis","volume":"40","author":"Lievano","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.11.072_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/JCM.43.1.30-35.2005","article-title":"External quality assessment for molecular detection of Bordetella pertussis in European laboratories","volume":"43","author":"Muyldermans","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2008.11.072_bib24","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1128\/JCM.01295-06","article-title":"Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis","volume":"44","author":"Register","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"December (Suppl. 4)","key":"10.1016\/j.vaccine.2008.11.072_bib25","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1086\/322564","article-title":"How to make sense of pertussis immunogenicity data","volume":"33","author":"Olin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.11.072_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/CVI.00364-06","article-title":"Cellular immunity in adolescents and adults following acellular pertussis vaccine administration","volume":"14","author":"Meyer","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"December (20)","key":"10.1016\/j.vaccine.2008.11.072_bib27","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"issue":"December (20)","key":"10.1016\/j.vaccine.2008.11.072_bib28","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.072_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.inf.0000210478.60841.69","article-title":"Epidemiology of pertussis","volume":"25","author":"Cherry","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"January (9\u201310)","key":"10.1016\/j.vaccine.2008.11.072_bib30","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0264-410X(01)00479-0","article-title":"Thirty-five years\u2019 experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity","volume":"20","author":"Njamkepo","year":"2002","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.072_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006454-199805000-00013","article-title":"Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination","volume":"17","author":"Baron","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"November (9191)","key":"10.1016\/j.vaccine.2008.11.072_bib32","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(99)01576-7","article-title":"Influence of vaccination coverage on pertussis transmission in France","volume":"354","author":"Grimprel","year":"1999","journal-title":"Lancet"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2008.11.072_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/341511","article-title":"Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage","volume":"186","author":"Gilberg","year":"2002","journal-title":"J Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.072_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"July (8)","key":"10.1016\/j.vaccine.2008.11.072_bib35","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.micinf.2006.04.014","article-title":"Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization","volume":"8","author":"Caro","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2008.11.072_bib36","unstructured":"Calendrier vaccinal 2008. Avis du Haut conseil de la sant\u00e9 publique. Bull Epidemiol Heb 2008;16\u201317:1\u201320."},{"key":"10.1016\/j.vaccine.2008.11.072_bib37","doi-asserted-by":"crossref","unstructured":"Bonmarin I, Levy-Bruhl D, Baron S, Guiso N, Njamkepo E, Caro V. Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill; 2007.","DOI":"10.2807\/esm.12.01.00678-en"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.11.072_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.11.072_bib39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/00006454-199711000-00007","article-title":"Efficacy of a two-component acellular pertussis vaccine in infants","volume":"16","author":"Liese","year":"1997","journal-title":"Pediatr Infect Dis J"},{"issue":"June (Suppl. 2)","key":"10.1016\/j.vaccine.2008.11.072_bib40","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1086\/515055","article-title":"A commentary on the pathogenesis of pertussis","volume":"28","author":"Hewlett","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.11.072_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1620\/tjem.130.105","article-title":"Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies)","volume":"130","author":"Toyota","year":"1980","journal-title":"Tohoku J Exp Med"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2008.11.072_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/IAI.46.3.733-739.1984","article-title":"Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation","volume":"46","author":"Meade","year":"1984","journal-title":"Infect Immun"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2008.11.072_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1440-1843.2003.00459.x","article-title":"A marked decrease in l-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained?","volume":"8","author":"Hodge","year":"2003","journal-title":"Respirology (Carlton, Vic)"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.11.072_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1309\/BANX-8JKM-TUQN-4D6P","article-title":"Marked increase in l-selectin-negative T cells in neonatal pertussis. The lymphocytosis explained?","volume":"114","author":"Hudnall","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2008.11.072_bib45","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/IAI.00414-07","article-title":"Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells","volume":"75","author":"Schneider","year":"2007","journal-title":"Infect Immun"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.11.072_bib46","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1002\/1521-4141(200211)32:11<3118::AID-IMMU3118>3.0.CO;2-B","article-title":"Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns","volume":"32","author":"Tonon","year":"2002","journal-title":"Eur J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.072_bib47","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/IAI.69.4.2650-2658.2001","article-title":"Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin","volume":"69","author":"Abramson","year":"2001","journal-title":"Infect Immun"},{"issue":"September (4563)","key":"10.1016\/j.vaccine.2008.11.072_bib48","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.6287574","article-title":"Phagocyte impotence caused by an invasive bacterial adenylate cyclase","volume":"217","author":"Confer","year":"1982","journal-title":"Science"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2008.11.072_bib49","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/IAI.61.10.4064-4071.1993","article-title":"Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin","volume":"61","author":"Khelef","year":"1993","journal-title":"Infect Immun"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2008.11.072_bib50","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.139.8.2749","article-title":"Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin","volume":"139","author":"Pearson","year":"1987","journal-title":"J Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.11.072_bib51","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1128\/IAI.72.9.5530-5533.2004","article-title":"Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells","volume":"72","author":"Bassinet","year":"2004","journal-title":"Infect Immun"},{"issue":"November (4)","key":"10.1016\/j.vaccine.2008.11.072_bib52","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1365-2958.2007.05972.x","article-title":"Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b\/CD18 (Mac-1)","volume":"66","author":"Perkins","year":"2007","journal-title":"Mol Microbiol"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2008.11.072_bib53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CDLI.10.4.637-642.2003","article-title":"T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice","volume":"10","author":"Ausiello","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.11.072_bib54","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect Immun"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2008.11.072_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1574-695X.2002.tb00594.x","article-title":"Evaluation of efficacy in terms of antibody levels and cell-mediated immunity of acellular pertussis vaccines in a murine model of respiratory infection","volume":"33","author":"Watanabe","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2008.11.072_bib56","first-page":"1","article-title":"Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","author":"CDC","year":"1997","journal-title":"MMWR Recomm Rep"},{"issue":"September (3 Pt 2)","key":"10.1016\/j.vaccine.2008.11.072_bib57","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 13 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatrics"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2008.11.072_bib58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/CDLI.11.6.1045-1053.2004","article-title":"Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States","volume":"11","author":"Baughman","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2008.11.072_bib59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CDLI.3.6.689-700.1996","article-title":"Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens","volume":"3","author":"Lynn","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"issue":"Mar (3)","key":"10.1016\/j.vaccine.2008.11.072_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/CVI.13.3.341-348.2006","article-title":"Characterization of serological responses to pertussis","volume":"13","author":"Watanabe","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.11.072_bib61","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"de Melker","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2008.11.072_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0264-410X(03)00514-0","article-title":"European Sero-Epidemiology Network: standardisation of the assay results for pertussis","volume":"22","author":"Giammanco","year":"2003","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.11.072_bib63","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/infdis\/169.6.1297","article-title":"Pertussis in Massachusetts, 1981\u20131991: incidence, serologic diagnosis, and vaccine effectiveness","volume":"169","author":"Marchant","year":"1994","journal-title":"J Infect Dis"},{"issue":"November (3\u20134)","key":"10.1016\/j.vaccine.2008.11.072_bib64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0264-410X(01)00343-7","article-title":"Ad hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27\u201328 July 2000","volume":"20","author":"Corbel","year":"2001","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.072_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2807\/esm.02.04.00167-en","article-title":"The European Sero-Epidemiology Network","volume":"2","author":"Osborne","year":"1997","journal-title":"Euro Surveill"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2008.11.072_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S0950268804003012","article-title":"The seroepidemiology of Bordetella pertussis infection in Western Europe","volume":"133","author":"Pebody","year":"2005","journal-title":"Epidemiol Infect"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.072_bib67","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/PL00015016","article-title":"Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children","volume":"18","author":"Wirsing von Konig","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2008.11.072_bib68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/CDLI.5.2.130-134.1998","article-title":"Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal","volume":"5","author":"Simondon","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2008.11.072_bib69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/CDLI.7.3.422-426.2000","article-title":"Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis","volume":"7","author":"Kosters","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.11.072_bib70","unstructured":"Schellekens JBH, Verbakel J, Boshuis H, Elvers L, Meijer B, Van Houte A, Peeters M. Serodiagnosis of Pertussis with Commercial ELISA\u2019s. In: Microbiology ASo, editor. 42th ICAAC; 2002; San Diego, California, US: American Society of Microbiology; 2002."},{"issue":"February (4)","key":"10.1016\/j.vaccine.2008.11.072_bib71","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1086\/381204","article-title":"Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis","volume":"38","author":"Cherry","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.072_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-3476(47)80280-X","article-title":"Studies on pertussis immunization","volume":"30","author":"Sako","year":"1947","journal-title":"J Pediatr"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.072_bib73","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/clinids\/20.5.1271","article-title":"Comparison of values of antibody to Bordetella pertussis antigens in young German and American men","volume":"20","author":"Cherry","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"January (1 Pt 1)","key":"10.1016\/j.vaccine.2008.11.072_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.1.1","article-title":"A comparative efficacy trial in Germany in infants who received either the Lederle\/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine","volume":"101","author":"Stehr","year":"1998","journal-title":"Pediatrics"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2008.11.072_bib75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/clinids\/1.3.401","article-title":"Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis","volume":"1","author":"Pittman","year":"1979","journal-title":"Rev Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2008.11.072_bib76","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00006454-199310000-00001","article-title":"Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine","volume":"12","author":"Robbins","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.11.072_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4615-5355-7_23","article-title":"Immunity to pertussis. Not all virulence factors are protective antigens","volume":"452","author":"Robbins","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2008.11.072_bib78","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1086\/322639","article-title":"Mass vaccination of children with pertussis toxoid\u2014decreased incidence in both vaccinated and nonvaccinated persons","volume":"33","author":"Taranger","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2008.11.072_bib79","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.vaccine.2006.09.050","article-title":"WHO Working Group on standardisation and control of acellular pertussis vaccines\u2014report of a meeting held on 16\u201317 March 2006, St. Albans, United Kingdom","volume":"25","author":"Xing","year":"2007","journal-title":"Vaccine"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2008.11.072_bib80","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.vaccine.2006.12.013","article-title":"The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP","volume":"25","author":"Robbins","year":"2007","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.11.072_bib81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1086\/426454","article-title":"The diphtheria and pertussis components of diphtheria-tetanus toxoids-pertussis vaccine should be genetically inactivated mutant toxins","volume":"191","author":"Robbins","year":"2005","journal-title":"J Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.11.072_bib82","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315318","article-title":"Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis","volume":"181","author":"Taranger","year":"2000","journal-title":"J Infect Dis"},{"issue":"January (3\u20134)","key":"10.1016\/j.vaccine.2008.11.072_bib83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.vaccine.2003.08.016","article-title":"WHO Working Group on the standardisation and control of pertussis vaccines\u2014report of a meeting held on 6\u20137 May 2003, Ferney Voltaire, France","volume":"22","author":"Corbel","year":"2004","journal-title":"Vaccine"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2008.11.072_bib84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/biol.1999.0209","article-title":"Informal consultation with manufacturers and WHO Ad hoc working group on mouse protection models for acellular pertussis vaccines. National institute for biological standards, 12 November 1998","volume":"27","author":"Corbel","year":"1999","journal-title":"Biologicals"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2008.11.072_bib85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijmm.2004.07.007","article-title":"Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses","volume":"294","author":"Godfroid","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.11.072_bib86","first-page":"167","article-title":"Pertussis antibodies, protection, and vaccine efficacy after household exposure","volume":"146","author":"Storsaeter","year":"1992","journal-title":"Am J Dis Child"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2008.11.072_bib87","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","article-title":"Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis","volume":"21","author":"Storsaeter","year":"2003","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.072_bib88","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/IAI.68.4.1934-1941.2000","article-title":"Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis","volume":"68","author":"Bassinet","year":"2000","journal-title":"Infect Immun"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2008.11.072_bib89","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/377283","article-title":"Crucial role of antibodies to pertactin in Bordetella pertussis immunity","volume":"188","author":"Hellwig","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.072_bib90","series-title":"Vaccines","article-title":"Pertussis vaccines","author":"Edwards","year":"2008"},{"issue":"February (7\u20138)","key":"10.1016\/j.vaccine.2008.11.072_bib91","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0264-410X(98)00273-4","article-title":"Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey","volume":"17","author":"Hoppenbrouwers","year":"1999","journal-title":"Vaccine"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2008.11.072_bib92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/14760584.6.1.47","article-title":"Acellular pertussis vaccines and the role of pertactin and fimbriae","volume":"6","author":"Poolman","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2008.11.072_bib93","unstructured":"WHO. Pertussis Vaccines\u2014WHO Position Paper. Weekly Epidemiological Record (http:\/\/wwwwhoint\/wer\/en\/). World Health Organization; 2005. p. 31\u20139."},{"key":"10.1016\/j.vaccine.2008.11.072_bib94","series-title":"Manual of clinical laboratory immunology","first-page":"338","article-title":"Serological responses to Bordetella pertussis","author":"Manclark","year":"1986"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T20:54:09Z","timestamp":1684788849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08015946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08015946"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}